期刊文献+

BCR/ABL P230阳性的慢性粒细胞白血病特殊外周血检查结果分析 被引量:2

Special hematological manifestations of P230 BCR/ABL positive chronic myeloid leukemia in peripheral blood
下载PDF
导出
摘要 目的分析1例BCR/ABL P230阳性慢性粒细胞白血病(CML)患者临床及实验室检查结果,与慢性中性粒细胞白血病(CNL)相鉴别,以提高对二者认识及诊治水平。方法收集患者临床资料及实验室检查,包括血象、骨髓象、组织化学染色、染色体检查、融合基因检测等进行综合分析。结果血常规:无贫血,白细胞、血小板增多,多次白细胞分类:中性粒细胞均>0.86。骨髓象:有核细胞增生极度活跃,粒系增生,以中晚期粒细胞为主,嗜酸粒细胞及嗜碱粒细胞易见;巨核细胞增生,血小板成堆多见。组织化学碱磷酶染色阴性。Ph染色体阳性,t(9;22)(q34;q11),BCR断裂点在μ区,与μ-BCR相应的有e19a2,其编码蛋白为P230。结论这种Ph+BCRμ区基因重排应诊断为CML,而不应诊断为CNL,无Ph染色体和BCR/ABL融合基因才是真正的CNL。 Objective To analyze the clinical and special laboratory features of one case with BCR/ABL P230 positive chronic myeloid leukemia(CML)patient through reviewing comprehensive literature and to identify the disease with chronic neutrophilic leukemia(CNL)and improve the level of diagnosis and treatment.Methods Laboratory tests included routine blood examination,bone marrow,histochemical staining,chromosome examination,detection of fusion gene and analysis comprehensively.Results Routine blood test did not show anemia,but increased white blood cells,platelets,many times white blood cell classification:neutrophil all〉0.86.The bone marrow showed very active and active proliferation of nuclear cells,and the proliferation of the cells in the middle and late stage,and eosinophils and basophils easily seen.Tissue chemical staining of alkali phosphatase was negative.Ph chromosome positive,t(9;22)(q34;q11),BCR breakpoint was in the μ-BCR,with the corresponding BCR of e19a2,coding protein was P230.Conclusion The Ph+BCR gene rearrangement should be diagnosed CML,and not diagnosed as CNL,no Ph chromosome and BCR/ABL fusion gene is the real CNL.
作者 杨洪乐 杨丽妙 李彦会 胡蕊 刘学广 杜欢欢 朱芸 Yang Hongle Yang Limiao Li Yanhui Hu Rui Liu Xueguang Du Huanhuan Zhu Yun(Department of Clinical Laboratory, the Second Hospital of Hebei Medical University, Shijiazhuang 050000 ,Chin)
出处 《临床荟萃》 CAS 2017年第3期249-251,共3页 Clinical Focus
关键词 白血病 髓系 慢性 BCR-ABL阳性 融合蛋白质类 骨髓检查 leukemia myelogenous chronic BCR-ABL positive fusion proteins bone marrow examination
  • 相关文献

参考文献13

二级参考文献105

  • 1卢兴国.四片联检模式在血液形态学诊断中的应用[J].临床检验杂志(电子版),2014,3(3):641-664. 被引量:3
  • 2江倩,陈珊珊,江滨,江浩,陆颖,丘镜莹,陆道培.Ph阳性慢性粒细胞白血病患者伊马替尼治疗后的Ph阴性异常克隆演变[J].中华血液学杂志,2005,26(1):23-26. 被引量:10
  • 3沈群,周建伟,朱光荣,杨月艳,仇海荣,朱广荣,夏雯,姜鹏君.慢性髓系白血病首发血小板显著增多[J].中国实验血液学杂志,2006,14(2):247-251. 被引量:3
  • 4王慧萍,李国霞,乔振华,王宏伟.联合应用细胞遗传学、巢式RT-PCR和FISH技术检测慢性髓系白血病治疗过程中的肿瘤负荷[J].中国实验血液学杂志,2007,15(2):237-241. 被引量:3
  • 5Sinclair PB,Nacheva EP,Laversha M,et al. Large deletions at the t(9 ;22)breakpoint are common and may identify a poor prognosis subgroup of patients with chronic myeloid leukaemia [ J ]. Blood, 2000,95(3) :738 -743.
  • 6Kolomietz E, A1-Maghrabi J, Brennan S, et al. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis [J]. Blood,2001,97( 11 ) :3581 -3588.
  • 7Quintas-Cardama A, Kantarjian H,Talpaz M, et al. Imatinib mesylate therapy may overcome the poor prognostic significance of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia[J]. Blood,2005,105 (6) :2281 -2286.
  • 8Lundan T,Volin L,Ruutu T,et al. Allogeneic stem cell transplantation reverses the poor prognosis of CML patients with deletions in derivative chromosome 9 [ J ]. Leukemia,2005,19 : 138 - 140.
  • 9Sebastian K, Markus P, Claudia H, et al. Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemia[ EB ]. Blood First Edition Paper, prepublished online April 24,2007 ; DOI 10.1182/blood 2007 - 02 - 07 4252.
  • 10陈灏珠.实用内科学.第12版.北京:人民卫生出版社,2005,1469-1471.

共引文献60

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部